Unlock instant, AI-driven research and patent intelligence for your innovation.
Pharmaceutical composition and application thereof using anophylline derivatives as active ingredients
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A kind of technology of fenugreek, derivative, applied in the pharmaceutical composition and application field of fenutraline derivative as active ingredient, can solve problems such as unreported
Active Publication Date: 2020-08-11
KUNMING INST OF BOTANY - CHINESE ACAD OF SCI
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0005] At present, there is no report on the medicines of the anophylline derivatives (1-6) provided by the present invention as melatonin and 5-hydroxytryptamine receptor agonists and active ingredients for antipsychotic diseases, and its derivatives or pharmaceutical compositions thereof are used as Melatonin and serotonin receptor agonists have not been reported in the preparation or treatment of antipsychotic drugs
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
preparation Embodiment 1
[0021] Anophylline (2mmol) was dissolved in 10mL anhydroustoluene with ethylamine, pyrrole, piperidine, N-isopropylpiperazine, N-methylhomopiperazine and homopiperazine (2-10mmol) respectively, and refluxed at 110°C To the end of the reaction, the solvent was recovered under reduced pressure to prepare a crude product, which was purified by silica gelcolumn chromatography (diethylamine / methanol / chloroform, v / v / v, 2 / 4 / 94~3 / 5 / 92) to obtain the target compound ( 1‐6):
[0022] Compound 1‐6 structure determination data:
[0023] N,N‐Diethyl‐3‐indolylmethylamine (N,N‐Diethyl‐3‐indolylmethylamine, 1): white powder, yield 97%. 1 H NMR (400MHz, CDCl 3 )δ H :8.93(s,1H,NH),7.78‐7.00(m,5H,H‐2,4,5,6,7),3.87(s,2H,‐CH 2 N),2.69‐2.65(m,4H,
[0024] N‐Pyrrolyl‐3‐indolylmethylamine (N‐Pyrrolyl‐3‐indolylmethylamine, 2): white powder, yield 96%. 1 H NMR (400MHz, CDCl 3 )δ H :9.27(s,1H,NH),7.75‐7.00(m,5H,H‐2,4,5,6,7),3.91(s,2H,CH 2 N),2.68(m,4H,H‐2',5'), Piperazinyl‐3‐indolylmethyl...
Embodiment 1
[0043] The anophylline derivative 1-6 prepared according to the method of Preparation Example 1 was dissolved in a small amount of DMSO separately or mixed, and then added with water for injection as usual, finely filtered, potted and sterilized to make an injection.
Embodiment 2
[0045] According to the method of Preparation Example 1, firstly prepare the stephanine derivatives 1-6, separately or mixed, after dissolving with a small amount of DMSO, dissolve it in sterile water for injection, stir to dissolve, and use a sterile suction filter funnelFiltration, and then aseptic fine filtration, sub-package in ampoules, freeze-drying at low temperature and then aseptically melt-seal to obtain powder injection.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides pharmaceutical compositions taking gramine derivatives (1-6) as active ingredients, application of the derivatives and the pharmaceutical compositions prepared from the derivatives as agonist for melatonin and a serotoninreceptor, and application of the derivatives and the pharmaceutical compositions prepared from the derivatives in preparation of medicines for treating or relieving central nervous system diseases related to the melatonin and the serotoninreceptor.
Description
technical field [0001] The present invention belongs to the technical field of medicines, in particular, it relates to a pharmaceutical composition with the anophylline derivatives shown in structural formulas 1-6 as active ingredients, their preparation methods, and the use of such derivatives and their pharmaceutical compositions as catharpine derivatives. Melatonin and serotoninreceptor agonists, and their application in the preparation of medicines for treating or improving central nervous system diseases related to melatonin and serotonin receptors. Background technique [0002] Melatonin receptor is a neuroendocrine hormone secreted by the pineal gland. It is controlled by the suprachiasmatic nucleus of the hypothalamus and can regulate the circadian rhythm. This rhythmic fluctuation shows that it reaches a peak at night and drops to a valley during the day. McCord and Allan discovered in 1917 that the bovine pineal gland can regulate changes in the skin of Rana pipie...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.